COVID Risk | Literature database and meta-analysis page 23

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.000 (0.970-1.040) ^§	Simonnet
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Hazard ratio: 1.060 (1.030-1.100) ^§	Wang
COVID-19 (severe/critical)	Patient characteristics	Age [>=65 years vs. <65 years]	Odds ratio: 16.320 (4.590-58.010)	Wu
COVID-19 (severe/critical)	Laboratory Findings	LDH [Abnormal vs. Normal]	Hazard ratio: 2.500 (1.200-5.200) ^§	Ji
COVID-19 (death)	Laboratory Findings	Procalcitonin [1 unit increase vs. Not applicable]	Hazard ratio: 1.110 (1.010-1.220) ^§	Gao
COVID-19 (death)	Laboratory Findings	Lymphocytes [1 unit increase vs. Not applicable]	Hazard ratio: 0.150 (0.030-0.780) ^§	Gao
COVID-19 (death)	Laboratory Findings	WBC [1 unit increase vs. Not applicable]	Hazard ratio: 1.090 (0.020-1.160) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.200 (1.050-1.380) ^§	Gao
COVID-19 (death)	Laboratory Findings	CRP [1 unit increase vs. Not applicable]	Hazard ratio: 1.010 (1.000-1.020) ^§	Gao
COVID-19 (death)	Laboratory Findings	Lymphocytes [1 unit increase vs. Not applicable]	Hazard ratio: 0.200 (0.030-1.220) ^§	Gao
COVID-19 (death)	Laboratory Findings	WBC [1 unit increase vs. Not applicable]	Hazard ratio: 1.040 (0.900-1.190) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.230 (1.000-1.510) ^§	Gao
COVID-19 (death)	Laboratory Findings	Lymphocytes [1 unit increase vs. Not applicable]	Hazard ratio: 0.160 (0.040-0.760) ^§	Gao
COVID-19 (death)	Laboratory Findings	WBC [1 unit increase vs. Not applicable]	Hazard ratio: 1.100 (1.020-1.190) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.250 (1.100-1.420) ^§	Gao
COVID-19 (death)	Laboratory Findings	Creatinine [1 unit increase vs. Not applicable]	Hazard ratio: 1.000 (0.970-1.030) ^§	Gao
COVID-19 (death)	Laboratory Findings	Urea [1 unit increase vs. Not applicable]	Hazard ratio: 1.040 (0.940-1.160) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.370 (1.190-1.590) ^§	Gao
COVID-19 (death)	Laboratory Findings	Hs-TnI [1 unit increase vs. Not applicable]	Hazard ratio: 1.030 (0.570-1.860) ^§	Gao
COVID-19 (death)	Laboratory Findings	CK-MB [1 unit increase vs. Not applicable]	Hazard ratio: 1.120 (0.910-1.390) ^§	Gao
COVID-19 (death)	Laboratory Findings	Myoglobin (MYO) [1 unit increase vs. Not applicable]	Hazard ratio: 1.006 (1.003-1.008) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.360 (1.180-1.570) ^§	Gao
COVID-19 (death)	Comorbidities	Coronary heart disease [Present vs. Not present]	Hazard ratio: 1.220 (0.420-3.520) ^§	Gao
COVID-19 (death)	Comorbidities	Hypertension [Present vs. Not present]	Hazard ratio: 1.610 (0.590-4.410) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.340 (1.190-1.520) ^§	Gao
COVID-19 (death)	Patient characteristics	Age [10 year increase vs. Not applicable]	Hazard ratio: 1.180 (0.720-1.920) ^§	Gao
COVID-19 (death)	Patient characteristics	Gender [Female vs. Male]	Hazard ratio: 1.080 (0.330-3.520) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.320 (1.120-1.560) ^§	Gao
COVID-19 (death)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Not applicable]	Hazard ratio: 1.370 (1.220-1.540)	Gao
COVID-19 (severe/critical)	Laboratory Findings	LDH [Abnormal vs. Normal]	Hazard ratio: 9.800 (2.800-33.800) ^§	Ji
COVID-19 (severe/critical)	Laboratory Findings	Lymphocytes [Abnormal vs. Normal]	Hazard ratio: 3.700 (1.800-7.800) ^§	Ji
COVID-19 (severe/critical)	Patient characteristics	Age [>60 years vs. <=60 years]	Hazard ratio: 3.000 (1.400-6.000) ^§	Ji
COVID-19 (severe/critical)	Comorbidities	Any comorbidity [Present vs. Not present]	Hazard ratio: 3.900 (1.900-7.900) ^§	Ji
COVID-19 (severe/critical)	Laboratory Findings	D-dimer [Abnormal vs. Normal]	Hazard ratio: 1.000 (0.500-2.100) ^§	Ji
COVID-19 (death)	Comorbidities	Diabetes [Present at admission vs. Not present]	Hazard ratio: 1.680 (0.340-8.160) ^§	Feng
COVID-19 (death)	Comorbidities	Cardiovascular disease [Present vs. Not present]	Hazard ratio: 0.590 (0.100-3.630) ^§	Feng
COVID-19 (death)	Laboratory Findings	LDH [1 unit increase (at admission) vs. Not applicable]	Hazard ratio: 1.002 (1.000-1.004) ^§	Feng
COVID-19 (death)	Comorbidities	Hypertension [Present vs. Not present]	Hazard ratio: 1.560 (0.420-5.830) ^§	Feng
COVID-19 (death)	Laboratory Findings	Creatine kinase [1 unit increase (at admission) vs. Not applicable]	Hazard ratio: 1.010 (1.009-1.020) ^§	Feng
COVID-19 (death)	Laboratory Findings	D-dimer [Abnormal at admission vs. Normal]	Hazard ratio: 3.260 (0.990-10.720) ^§	Feng
COVID-19 (death)	Laboratory Findings	Lymphocytes [Abnormal at admission vs. Normal]	Hazard ratio: 0.660 (0.220-1.960) ^§	Feng
COVID-19 (death)	Patient characteristics	Age [>=75 years vs. <75 years]	Hazard ratio: 6.070 (1.650-22.350) ^§	Feng
COVID-19 (death)	Complications	Bacterial infection [Present vs. Not present]	Hazard ratio: 1.520 (0.710-3.240) ^§	Wang
COVID-19 (death)	Complications	Cardiac insufficiency [Present vs. Not present]	Hazard ratio: 1.110 (0.590-2.060) ^§	Wang
COVID-19 (death)	Complications	Acute respiratory distress syndrome [Present vs. Not present]	Hazard ratio: 29.330 (12.370-69.580) ^§	Wang
COVID-19 (death)	Complications	Acute kidney injury [Present vs. Not present]	Hazard ratio: 1.160 (0.560-2.410) ^§	Wang
COVID-19 (death)	Complications	Arrhythmia [Present vs. Not present]	Hazard ratio: 0.750 (0.370-1.530) ^§	Wang
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Hazard ratio: 1.010 (0.980-1.050) ^§	Wang
COVID-19 (severe/critical)	Laboratory Findings	Serum creatinine [1 unit increase vs. Normal]	Odds ratio: 1.000 (0.990-1.010) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase vs. Normal]	Odds ratio: 3.240 (0.620-16.980) ^§	Chen

If a relevant publication escaped our attention, please contact us.